Industry News
Increased Risk Of Fatal Side Effects From 3 'Targeted' Cancer Drugs
Feb 07, 2012
Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that the risk remains low, but should be taken into account by physicians and patients. The incidence of fatal complications was 1... Read More
More Accurate Diagnosis Of Genetic Mutations Expected Using New Virtual Tool
Feb 07, 2012
DNA sequencing to detect genetic mutations can aid in the diagnosis and selection of treatment for cancer. Current methods of testing DNA samples, Sanger sequencing and pyrosequencing, occasionally produce complex results that can be difficult or impossible to interpret... Read More
A Particular Breast Cancer Subtype May Respond To Drugs Targeting Chromosomal Instability
Feb 07, 2012
Another layer in breast cancer genetics has been peeled back. A team of researchers at Jefferson's Kimmel Cancer Center (KCC) led by Richard G. Pestell, M.D., PhD... Read More
New Prostate Cancer Drug Target Identified
Feb 07, 2012
Research led by Wanguo Liu, PhD, Associate Professor of Genetics at LSU Health Sciences Center New Orleans, has identified a new protein critical to the development and growth of prostate cancer. The findings are published online in the Early Edition of Proceedings of the National Academy of Sciences, available the week of February 6, 2012. Dr... Read More
News From The Annals Of Internal Medicine: Feb. 7 2012
Feb 07, 2012
1... Read More
Study Identifies Molecular Switch That Allows Melanoma To Resist Therapy
Feb 07, 2012
The National Cancer Institute (NCI) estimates that as many as one in 51 men and women will be diagnosed with melanoma - the deadliest form of skin cancer - at some point during their lifetimes. A research team led by Ze'ev Ronai, Ph.D... Read More
Breakthroughs Demonstrate Importance Of Targeted Therapies For Lung Cancer
Feb 07, 2012
Different kinds of lung cancer behave in different ways, suggesting they are fundamentally different diseases. According to a University of Colorado Cancer Center study published in Cancer, the official journal of the American Cancer Society, different subgroups of non-small cell lung cancer (NSCLC) show distinct patterns of spread in the body... Read More
Reviewing Ways To Balance The Benefits Of Oxaliplatin With Its Side Effects When Treating Colon Cancer
Feb 07, 2012
The drug oxaliplatin is a major reason the prognosis for metastatic colon cancer has gone from an expected survival of several months to a couple years. Unfortunately, the drug can also carry with it debilitating neurological side effects, which generally start as the sensation of pins and needles in fingers and toes and can leave patients unable to walk or dress independently... Read More
No Breast Cancer Protections From Soy Isoflavone Supplements
Feb 07, 2012
Soy isoflavone supplements did not decrease breast cancer cell proliferation in a randomized clinical trial, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research. Lead researcher Seema A. Khan, M.D., professor of surgery at the Robert H... Read More
'Biopsy In A Blood Test' - Effective New Diagnostic For Cancer
Feb 07, 2012
Scientists from The Scripps Research Institute, Scripps Health, and collaborating cancer physicians have successfully demonstrated the effectiveness of an advanced blood test for detecting and analyzing circulating tumor cells (CTCs) - breakaway cells from patients' solid tumors - from cancer patients... Read More
Previous Page Next Page